These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25432076)

  • 1. Present and future of developmental neuropsychopharmacology.
    Arango C
    Eur Neuropsychopharmacol; 2015 May; 25(5):703-12. PubMed ID: 25432076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychodynamic perspectives on psychotropic medications for children and adolescents.
    Chubinsky P; Hojman H
    Child Adolesc Psychiatr Clin N Am; 2013 Apr; 22(2):351-66. PubMed ID: 23538017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic drugs and paediatrics: a critical need for more clinical trials.
    Tishler CL; Reiss NS
    J Med Ethics; 2012 Apr; 38(4):250-2. PubMed ID: 22048850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in psychopharmacology of children and adolescents.
    Koelch M; Schnoor K; Fegert JM
    Curr Opin Psychiatry; 2008 Nov; 21(6):598-605. PubMed ID: 18852568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology: clinical implications of brain neurochemistry.
    Scheffer RE
    Pediatr Clin North Am; 2006 Aug; 53(4):767-75. PubMed ID: 16873004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo effect in child and adolescent psychiatric trials.
    Parellada M; Moreno C; Moreno M; Espliego A; de Portugal E; Arango C
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):787-99. PubMed ID: 22030230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic and cosmetic psychopharmacology. Risks and limits].
    Echarte Alonso LE
    Cuad Bioet; 2009; 20(69):211-30. PubMed ID: 19507923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
    Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current and potential impact of genetics and genomics on neuropsychopharmacology.
    Harrison PJ
    Eur Neuropsychopharmacol; 2015 May; 25(5):671-81. PubMed ID: 23528807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic drug prescription in adolescent].
    Laget J
    Rev Med Suisse Romande; 2000 Feb; 120(2):117-22. PubMed ID: 10748697
    [No Abstract]   [Full Text] [Related]  

  • 12. The "systems approach" to treating the brain: opportunities in developmental psychopharmacology
.
    Bussone S; Iacono LL
    Dialogues Clin Neurosci; 2019; 21(2):211-215. PubMed ID: 31636495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child and adolescent neuropsychopharmacology: now or never.
    Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):563-4. PubMed ID: 21669515
    [No Abstract]   [Full Text] [Related]  

  • 14. Developmental perspectives in pediatric psychopharmacology.
    Vitiello B; Jensen PS
    Psychopharmacol Bull; 1995; 31(1):75-81. PubMed ID: 7675993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Horizons in Pediatric Psychopharmacology.
    Khan S; Rathore V; Khan S
    Drug Dev Res; 2016 Dec; 77(8):474-478. PubMed ID: 27633258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring in child and adolescent psychiatry.
    Egberts KM; Mehler-Wex C; Gerlach M
    Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking back to the future of psychopharmacology.
    Hirshbein L
    J Nerv Ment Dis; 2012 Dec; 200(12):1109-12. PubMed ID: 23183368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
    Hendriksen H; Groenink L
    Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.